The Patent Finder

Enthalpy Analytical, Inc.

Also on record
Records under this name other than the patents Enthalpy Analytical, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Enthalpy Analytical, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,566,421Encapsulated Sorbent Tube
Term ended
Term ended May 5, 2023 · High confidence
Term endedTerm ended May 5, 2023High confidence
US 6,924,288Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
Formerly held
Term ended
Term ended May 1, 2023 · USPTO record
Term endedTerm ended May 1, 2023USPTO record
US 7,189,725Enantiomerically pure opioid diarylmethylpiperazine as a cardioprotection agent
Formerly held
Term ended
Term ended Oct 8, 2022 · USPTO record
Term endedTerm ended Oct 8, 2022USPTO record
US 7,683,168Compositions of novel opioid compounds and method of use thereof
Formerly held
Lapsed on the fee record
Ended Mar 23, 2022 · USPTO record
Lapsed on the fee recordEnded Mar 23, 2022USPTO record
US 8,575,169Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
Formerly held
Lapsed on the fee record
Ended Nov 5, 2021 · USPTO record
Lapsed on the fee recordEnded Nov 5, 2021USPTO record
US 8,476,280Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
Formerly held
Lapsed on the fee record
Ended Jul 2, 2021 · USPTO record
Lapsed on the fee recordEnded Jul 2, 2021USPTO record
US 7,314,880Cardioprotective delta opioid receptor agonists and methods of using same
Formerly held
Lapsed on the fee record
Ended Jan 1, 2020 · USPTO record
Lapsed on the fee recordEnded Jan 1, 2020USPTO record
US 6,630,515Urinary incontinence therapy
Formerly held
Term ended
Term ended Aug 21, 2018 · USPTO record
Term endedTerm ended Aug 21, 2018USPTO record
US 7,030,124Method of treating depression with delta receptor agonist compounds
Formerly held
Lapsed on the fee record
Ended Apr 18, 2018 · USPTO record
Lapsed on the fee recordEnded Apr 18, 2018USPTO record
US 6,300,332Methods for reducing respiratory depression and attendant side effects of mu opioid compounds
Formerly held
Lapsed on the fee record
Ended Oct 9, 2009 · USPTO record
Lapsed on the fee recordEnded Oct 9, 2009USPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited